SEC Filing Summary: Ecology Coatings, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on November 29, 2011, by Ecology Coatings, Inc. (Nevada). The report discloses a material definitive agreement entered into on November 23, 2011. Note: The request metadata references "ABVC BIOPHARMA, INC.", but the filing text explicitly identifies the registrant as "ECOLOGY COATINGS, INC."
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on the terms of a new licensing agreement.
Material Changes and Agreements
On November 23, 2011, the company entered into a License Agreement with BASF Coatings GmbH ("BASF"). Key terms include:
- Licensed Patents: Four patents (EP 1 723 180, US 7,323,248, US 7,153,892, and US 7,498,362).
- License Type: Non-exclusive license granted to BASF.
- Royalty Structure:
- EP 1 723 180: 0.5% of net sales in Europe; 2.5% of net sales outside Europe.
- US Patents (7,323,248, 7,153,892, 7,498,362): 2.5% of net sales outside Europe.
- Term: The agreement terminates upon the expiration of the last licensed patent.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond the standard disclosure of the agreement's existence. No unusual items or contingencies are detailed in the text provided.
Investor Verification Checklist
- Verify the correct registrant name (Ecology Coatings, Inc. vs. ABVC Biopharma, Inc.) to ensure the correct entity is being analyzed.
- Confirm the commercial status and remaining life of the four licensed patents (EP 1 723 180, US 7,323,248, US 7,153,892, US 7,498,362).
- Review the full text of Exhibit 10.95 (License Agreement) for definitions of "net sales" and any minimum royalty guarantees not summarized here.
- Assess BASF's current product portfolio to estimate potential royalty revenue streams.